LGND
NASDAQ · Pharmaceuticals
Ligand Pharmaceuticals
$220.48
-0.93 (-0.42%)
Performance
1D
—
1W
—
1M
—
3M
+18.56%
6M
+9.54%
1Y
+107.26%
YTD
+15.97%
Open$221.41
Previous Close$221.41
Day High$225.82
Day Low$218.00
52W High$247.38
52W Low$98.89
Volume—
Avg Volume253.0K
Market Cap4.13B
P/E Ratio33.17
EPS$5.88
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$193.47
Above
SMA 200
$162.08
Above
RSI (14)
38.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
15 analysts
Price Target
-85.7% upside
Current
$220.48
$220.48
Target
$31.56
$31.56
$18.80
$31.56 avg
$35.41
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 246.31M | 221.96M | 944.72M |
| Net Income | 114.34M | 92.74M | 258.92M |
| Profit Margin | 46.4% | 44.1% | 27.4% |
| EBITDA | 67.64M | 57.91M | 346.84M |
| Free Cash Flow | — | — | 167.31M |
| Rev Growth | +11.0% | +11.0% | +8.5% |
| Debt/Equity | 0.44 | 0.44 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $966.99 | +1.95% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.43 | +0.05% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.28 | -0.09% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.81 | +0.51% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $55.67 | -0.87% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $76.67 | -7.44% | 21.5 | 57.37B |